EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Homoharringtonine Inhibits CVS-11 and Clinical Isolates of Rabies Virus In Vitro: Identified via High-Throughput Screening of an FDA-Approved Drug Library

Kalenahalli Rajappa Harisha, Varun Kailaje, Ravinder Reddy Kondreddi, Chandra Sekhar Gudla, Shraddha Singh, Sharada Ramakrishnaiah, Shrikrishna Isloor, Shridhar Narayanan, Radha Krishan Shandil iD, Gudepalya Renukaiah Rudramurthy iD

Viruses · 2025

DOI: 10.3390/v17070945 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Kalenahalli Rajappa Harisha und 9 weiteren Autor:innen. Beteiligte Einrichtung: Foundation for Neglected Disease Research (FNDR), Bengaluru 561203, India. Hauptthemen laut MEDLINE: Antiviral Agents, Rabies virus, Homoharringtonine. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rabies, a viral encephalitis caused by rabies virus (RABV), is 100% fatal upon the onset of symptoms. Effective post-exposure prophylaxis (PEP) measures are available, but they are often difficult to access in low-income countries. WHO estimates about 59,000 deaths due to rabies globally, and the majority are contributed by developing countries. Hence, developing drugs for the treatment of post-symptomatic rabies is an urgent and unmet demand. It is worth noting that previous efforts regarding antiviral strategies, such as small-interfering RNA, antibodies and small-molecule inhibitors, against the rabies virus have failed to show efficacy in pre-clinical studies, especially when the virus has reached the central nervous system (CNS). Therefore, drug repurposing seems to be an alternative tool for the development of new anti-rabies drugs. We validated and used a high-throughput, FITC-conjugated antibody-based flow cytometry assay to expedite the identification of repurposable new drug candidates against the RABV. The assay was validated using ribavirin and salinomycin as reference compounds, which showed EC50 values of 10.08 µM and 0.07 µM, respectively. We screened a SelleckChem library comprising 3035 FDA-approved compounds against RABV (CVS-11) at 10 µM concentration. Five compounds (clofazimine, tiamulin, difloxacin, harringtonine and homoharringtonine) were active against RABV, with greater than 90% inhibition. Homoharringtonine (HHT) identified in the present study is active against laboratory-adapted RABV (CVS-11) and clinical isolates of RABV, with an average EC50 of 0.3 µM in both BHK-21 and Neuro-2a cell lines and exhibits post-entry inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antiviral AgentsRabies virusHomoharringtonineHigh-Throughput Screening AssaysAnimalsHumansDrug RepositioningCell LineRabiesUnited StatesSmall Molecule Libraries

Stichwörter der Autor:innen

CVS-11RABVclinical isolateflow cytometryhigh-throughput assayhomoharringtonine

Substanzen

Antiviral AgentsHomoharringtonineSmall Molecule Libraries

Autor:innen und Institutionen

  • Foundation for Neglected Disease Research (FNDR), Bengaluru 561203, India.
  • Veterinary College, Karnataka Veterinary, Animal and Fisheries Sciences University (KVAFSU), Hebbal, Bengaluru 560024, India.

ORCID-Profile: Radha Krishan Shandil, Gudepalya Renukaiah Rudramurthy

Zitieren

APA

Harisha, K. R., Kailaje, V., Kondreddi, R. R., Gudla, C. S., Singh, S., Ramakrishnaiah, S., Isloor, S., Narayanan, S., Shandil, R. K., & Rudramurthy, G. R. (2025). Homoharringtonine Inhibits CVS-11 and Clinical Isolates of Rabies Virus In Vitro: Identified via High-Throughput Screening of an FDA-Approved Drug Library. Viruses. https://doi.org/10.3390/v17070945

Vancouver

Harisha KR, Kailaje V, Kondreddi RR, Gudla CS, Singh S, Ramakrishnaiah S, et al. Homoharringtonine Inhibits CVS-11 and Clinical Isolates of Rabies Virus In Vitro: Identified via High-Throughput Screening of an FDA-Approved Drug Library. Viruses. 2025. doi:10.3390/v17070945

BibTeX
@article{Harisha2025,
  author = {Harisha, Kalenahalli Rajappa and Kailaje, Varun and Kondreddi, Ravinder Reddy and Gudla, Chandra Sekhar and Singh, Shraddha and Ramakrishnaiah, Sharada and Isloor, Shrikrishna and Narayanan, Shridhar and Shandil, Radha Krishan and Rudramurthy, Gudepalya Renukaiah},
  title = {Homoharringtonine Inhibits CVS-11 and Clinical Isolates of Rabies Virus In Vitro: Identified via High-Throughput Screening of an FDA-Approved Drug Library},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17070945}
}
Kostenlos starten →